Status:

COMPLETED

Smoking Reduction In Gravid Substance Use Disorders

Lead Sponsor:

University of Alabama at Birmingham

Conditions:

Tobacco Smoking in Mother Complicating Pregnancy

Tobacco Use Disorder

Eligibility:

FEMALE

16-45 years

Phase:

NA

Brief Summary

The aim of this study is to encourage smoking cessation in women with substance use disorders by providing knowledge of expired carbon monoxide. We hypothesize that women who are provided knowledge of...

Detailed Description

This is a randomized controlled trial. Pregnant smokers who are substances users who meet inclusion criteria will be offered participation in the study at their first obstetrical appointment. Patients...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • i. Age 16-45
  • ii. Singleton gestation
  • iii. Gestational age at enrollment \<24 weeks
  • iv. Substance use disorder defined as modified National Institute on Drug Abuse ASSIST ≥4
  • v. Cigarette smoker using ≥10 cigarettes/day interested in quitting
  • Exclusion criteria:
  • i. Known or suspected fetal growth restriction at enrollment
  • ii. Known fetal anomaly, aneuploidy, or demise
  • iii. Not interested in smoking cessation or reduction during pregnancy
  • iv. E-cigarette use

Exclusion

    Key Trial Info

    Start Date :

    February 15 2021

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    December 1 2023

    Estimated Enrollment :

    74 Patients enrolled

    Trial Details

    Trial ID

    NCT04132232

    Start Date

    February 15 2021

    End Date

    December 1 2023

    Last Update

    August 5 2024

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    University of Alabama

    Birmingham, Alabama, United States, 35233